Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| AVALON PHARMA (NASDAQ: AVRX) | Delayed: 0.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.59 | 52 Week High | $1.45 | |||
| Open | $0.59 | 52 Week Low | $0.07 | |||
| Day High | $0.59 | P/E | N/A | |||
| Day Low | $0.59 | EPS | $-1.24 | |||
| Volume | 35,400 | |||||
| (NASDAQ: NXTC) | Delayed: 4.85 +0.13 (2.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.72 | 52 Week High | $ | |||
| Open | $4.96 | 52 Week Low | $ | |||
| Day High | $5.28 | P/E | N/A | |||
| Day Low | $4.53 | EPS | $ | |||
| Volume | 34,141 | |||||
